BridgeMD
New treatment option for Non ST Segment Elevation Acute Coronary Syndrome
Official title Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation
ClinicalTrials.gov ID: NCT06695429
What this study is testing
- What it's testing
- The goal of this study is to compare the possible beneficial effect of beetroot juice supplementation versus the usual management during hospitalization to prevent contrast-induced nephropathy after cardiac catheterizations. The study includes patients diagnosed with non-ST elevation acute coronary syndrome with a possible indication for catheterism and high risk of kidney injury related to iodinated contrast.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of Acute Coronary Syndrome without persistent ST segment elevation, with recommendation for invasive management according to the actual...
- At least moderate or high risk of nephropathy associated with iodinated contrast (Mehran score (without including contrast volume) ≥ 6).
You likely can't join if
- \<18 years old or without capacity to give consent.
- Refusal to participate in the study.
- Known hypersensitivity to beetroot or any of its allergens.
- Pregnant.
- Inability to take food orally
- Serious illnesses (not related to ACS or kidney failure), which limits their life expectancy to a period predictably less than 1 year.
See the full eligibility criteria
- Diagnosis of Acute Coronary Syndrome without persistent ST segment elevation, with recommendation for invasive management according to the actual Clinical practice guidelines
- At least moderate or high risk of nephropathy associated with iodinated contrast (Mehran score (without including contrast volume) ≥ 6).
- \<18 years old or without capacity to give consent.
- Refusal to participate in the study.
- Known hypersensitivity to beetroot or any of its allergens.
- Pregnant.
- Inability to take food orally
- Serious illnesses (not related to ACS or kidney failure), which limits their life expectancy to a period predictably less than 1 year.
- On dialysis or predialysis at the time of inclusion.
- ACS with persistent ST segment elevation before inclusion.
- Shock or inotrope dependence at the time of inclusion
- PCI already performed before inclusion.
- Patients receiving intravenous nitroglycerin for \> 1 hour before inclusion
The study team makes the final eligibility decision.
Where it's taking place
- Cartagena, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cartagena, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.